RECRUITING
I'm interested ...!!
Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease
The purpose of this study is to evaluate the feasibility and preliminary efficacy of the Promoting Resilience in Stress Management (PRISM) intervention in patients with adult congenital heart disease.
Conditions:
🦠 Congenital Heart Disease
🗓️ Study Start (Actual) 15 March 2023
🗓️ Primary Completion (Estimated) December 2024
✅ Study Completion (Estimated) December 2024
👥 Enrollment (Estimated) 86
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Seattle, Washington, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * adults with moderate or complex ACHD, stages B, C, or D as defined by the 2018 ACHD guidelines
    • * receive care in our health system

    Exclusion Criteria:

    • * diagnosis of another life-limiting illness
    • * inability to participate in study activities independently and in English
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 1 February 2021
  • First Submitted that Met QC Criteria 3 February 2021
  • First Posted 4 February 2021

Study Record Updates

  • Last Update Submitted that Met QC Criteria 27 January 2024
  • Last Update Posted 30 January 2024
  • Last Verified January 2024
I'm interested ...!!